Known globally for patented CELOX™ technology and haemostatic innovations – including CELOX™ Rapid Gauze, CELOX™ Granules and more recently CELOX™ PPH – the company has built a reputation for developing advanced wound care dressings for the management of acute and chronic wounds, along with life-saving solutions that stop bleeding fast, even in the most challenging of conditions across pre-hospital and hospital settings. The company continues to invest in CELOX™ technology within wound management and other pioneering medical solutions under the CELOX Medical name, reinforcing its position as a leader in the med-tech industry.

Russ Mably CEO, CELOX Medical, said: “Rebranding as CELOX Medical underscores our dedication to the products and technologies that have earned the trust of healthcare providers, military personnel and first responders around the world. This evolution reflects our mission to save and improve people’s lives by stopping bleeding and supporting the healing of traumatic and chronic wounds through continual product innovation using patented and evidence-based technologies”.

For more information about the rebranding or to learn more about CELOX Medical’s products, visit www.celoxmedical.com or contact us at info@celoxmedical.com.